Kang-Shen Yao

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-<i>raf</i>-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

James Stevenson, Kang-Shen Yao, Maryann Gallagher et al. · Journal of Clinical Oncology · 1999 · 131 citations

Medicine, Oncology, Pharmacology +15

Apoptosis in Human Adenocarcinoma HT29 Cells Induced by Exposure to Hypoxia

Kang-Shen Yao, Marcia M. Clayton, P J O'Dwyer · JNCI Journal of the National Cancer Institute · 1995 · 93 citations

Medicine, Cancer Biology, Oncology +16

Involvement of NF-κB in the induction of NAD(P)H: Quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C

Kang-Shen Yao, Peter J. O’Dwyer · Biochemical Pharmacology · 1995 · 90 citations

Life Sciences, Biochemistry, Molecular Biology +12

Reversal of cisplatin resistance in human ovarian cancer cell lines by a c- jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype

Bin Pan, Kang-Shen Yao, Brett P. Monia et al. · Biochemical Pharmacology · 2002 · 36 citations

Medicine, Molecular Biology, Oncology +16